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Peripheral angioplasty with same-day discharge in
patients with intermittent claudication
Gabriel Akopian, MD, and Steven G. Katz, MD, Pasadena, Calif
Background: As the number of endovascular interventions increase and resources become scarce, surgeons need to be
aware of cost-effective and efficient practice options. Many surgeons routinely admit their patients for overnight
observation after uneventful endovascular interventions. Although this may be appropriate for patients with tissue loss
and rest pain, we believe that peripheral angioplasty in patients with claudication can be safely performed as an outpatient
procedure with significant cost savings.
Methods: All patients with intermittent claudication undergoing peripheral angioplasty by a single vascular surgeon were
enrolled prospectively in a same-day discharge protocol. Involved arteries and use of stent and closure device were
recorded. Time to mobilization and time to discharge were determined. Patients were observed in an observation unit by
a registered nurse, and were examined by the surgeon at the time of ambulation and before discharge. Patients were
admitted to the hospital if complications arose during the predetermined observation period. Periprocedural complica-
tions and reasons for admission were noted. Patients were evaluated at 1 week, 6 weeks, and 3 to 6 months after the
intervention.
Results:During 27 months, 112 interventions were performed in 97 patients. The superficial femoral artery was the most
frequent site of intervention (47%). Multiple sites had angioplasty in 27 (24%) procedures. Nine (8%) procedures resulted
in admission. One patient was admitted for a major puncture site hematoma requiring blood transfusion, two patients for
observation of a minor hematoma at the puncture site, one for chest pain, and one for observation of transient
bradycardia. The mean time to mobilization was 1.4  1.3 hours, and the mean time to discharge was 2.8  1.2 hours.
The average postprocedural cost for patients undergoing same-day discharge was $320 per patient, which contrasts with
$1800 for routine overnight observation. No deaths or unplanned admissions to the hospital occurred <30 days of
intervention.
Conclusions: Same-day discharge after peripheral angioplasty is safe and cost-effective. Need for admission is evident
within 2 hours. Routine admission after peripheral angioplasty for patients with claudication is unnecessary and should
no longer be the standard of care. ( J Vasc Surg 2006;44:115-8.)After the introduction of the coaxial catheter1 in the
1960s and the subsequent creation of the balloon angio-
plasty catheter2 a decade later, percutaneous transluminal
angioplasty (PTA) became an acceptable form of treat-
ment for patients with occlusive arterial disease. Over the
last two decades, PTA has seen tremendous growth as a
treatment option for peripheral vascular disease. With an
ever-increasing population of elderly,3 the prevalence of
peripheral vascular disease and vascular interventions is
expected to rise. Because catheter based procedures are
now being performed with minimal complications, the
appropriateness of routine hospitalization after these pro-
cedures should be brought into question.
The Society of Interventional Radiology Standards of
Practice Committee guidelines4 in 2003 called for over-
night observation after PTA on the basis of the limited
number of studies that addressed this issue. Although di-
agnostic angiography is routinely performed as a same-day
procedure, outpatient PTA has been limited to a few cen-
ters. Our preliminary observation suggested that many
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claudication did not require hospital admission. In an at-
tempt to determine the safety, efficacy, and cost benefits of
outpatient PTA, we prospectively enrolled 112 patients in a
study protocol of same-day discharge to test this hypothe-
sis. This report focuses on the feasibility of same-day dis-
charge from the short-term complication rates and cost
analysis in this series of patients.
MATERIAL AND METHODS
Between January 1, 2003, and March 31, 2005, all
patients admitted for elective percutaneous interventions
were prospectively enrolled in a same-day discharge proto-
col. Interventions were performed by or under the super-
vision of one vascular surgeon (S. G. K.). Data were col-
lected according to the guidelines set forth by the Society
for Vascular Surgery and the International Society for Car-
diovascular Surgery,5 stratified by Transatlantic Intersoci-
etal Consensus (TASC) classification,6 and analyzed on an
intent-to-treat basis. When multiple segments underwent
intervention at one setting, the highest TASC classification
lesion was recorded. Patient demographics, presence of
comorbidities, history of smoking, use of anticoagulants,
stent placement, location of disease, use of closure device,
and prior vascular interventions were recorded. The proto-
col was approved by the institutional review board, and
patients gave written informed consent.
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the intervention and had adequate home support. None
were from nursing homes, although16 were from assisted
living facilities. The payer mix for this population of pa-
tients was 43% Medicare, 37% managed care, and 20%
private pay. None of the payers require admission or dis-
charge after endovascular interventions.
Patients did not undergo prescreening, and all inter-
ventions were planned within the same-day protocol. No
patients were admitted the night before the intervention.
Before the procedure, patients routinely underwent duplex
evaluation of their lower extremities for planning purposes
only. The preoperative duplex result did not change the
decision to enroll the patients in the same-day protocol.
All patients were begun on clopidogrel (75 mg daily)
beginning 4 days before the intervention. Patients able to
tolerate aspirin were also given 325 mg daily. Warfarin was
discontinued 72 hours before the procedure, and proce-
dures were postponed if the international normalized ratio
was 2.0.
Vascular access was obtained through a transfemoral
approach using the micropuncture technique. Diagnostic
arteriography was performed immediately before the inter-
vention. All patients were systemically anticoagulated with
heparin (5000 U). Stents were routinely placed after iliac
angioplasty per surgeon preference and initially in infrain-
guinal vessels if flow-limiting dissection or incomplete an-
gioplasty (residual stenosis30%) was noted. Beginning in
January 2004, stents were routinely placed after superficial
femoral artery and popliteal artery angioplasty as part of an
ongoing protocol studying the results of primary stenting
of the infrainguinal vessels. For occlusions 5 cm, subinti-
mal angioplasty techniques were used in almost all of the
patients. For occlusions 5 cm, both transluminal and
subintimal techniques were used.
Placement of the Angio-Seal Vascular Closure Device
(St. JudeMedical, Inc., St. Paul, Minn) was attempted after
all procedures if the puncture site was in the common
femoral artery and if there was40% stenosis1 cm of the
puncture site.7,8 Feasibility of closure device deployment
was angiographically determined. When a closure device
was not successfully deployed, the physician performed
manual groin compression at the groin access site for 10
minutes, re-evaluated for bleeding or hematoma, and pres-
sure was reapplied if there was bleeding or an expanding
hematoma. Heparin was not reversed at the conclusion of
the procedure.
Patients were ambulated in 1 hour after having success-
ful placement of a closure device and considered for dis-
charge in 2 hours if their post-procedure course was un-
complicated. If manual compression was used, patients
were ambulated after 4 hours and considered for discharge
shortly thereafter.
Patients were observed in a four-bed observation unit
staffed by one registered nurse. Time to ambulation and
time to discharge were determined at the end of the proce-
dure and adhered to if there were no complications. All
procedures were started between 8 AM and 3 PM and com-pleted between 9 AM and 5 PM. There were no payer
requirements that would alter the decision to admit or
discharge.
Patients underwent duplex evaluation at 6 weeks and
every 3 months for the first year, and every 6 months
thereafter. Patients were seen in the office at 1 week, 6
weeks, and every 3 months for the first year, and every 6
months thereafter. Additional phone calls were not rou-
tinely made, and patients were only seen outside of this
follow-up schedule if problems arose.
Cost analysis data were collected from the hospital’s
business office. Cost analysis was performed on actual costs
rather than patient charges. Hospital cost for a 1-hour stay
in the observation unit is $115, and an overnight stay in an
inpatient surgical bed is $1800. The average cost for pa-
tients being discharged was calculated by multiplying the
average length of stay by $115. Data are provided as counts
or means  standard deviation. Analysis was performed
using SAS (SAS Inc, Cary, NC).
RESULTS
During the 27-month study period, 112 consecutive
procedures were performed in 97 patients. Twenty-eight
additional interventions, which are not included in this
analysis, were performed in other patients for tissue loss or
rest pain. The mean age for the group was 74  9 years.
There were 49 men and 48 women. In 45 procedures
(40%), the patient had undergone a prior vascular interven-
tion.
The most common comorbidity was hypertension
(79%), followed by tobacco use (55%) (Table I). In 70
procedures (63%) the patients had Rutherford category 3
(severe) claudication. In 42 procedures (38%) the patients
had Rutherford category 2 (moderate) claudication. Inter-
ventions were not performed on patients with category 1
(mild) claudication. There were 87 interventions per-
formed on TASC category A and B lesions, and 25 were
performed on TASC C and D lesions.
The most common site of intervention was the super-
ficial femoral artery (SFA) in 53 procedures (Table II).
Angioplasty was performed on a single segment during 80
procedures (71%) and on multiple segments during 27
procedures (24%). Five patients (5%) failed treatment be-
cause the lesion could not be traversed. These patients are
Table I. Comorbidities of study patients
Comorbidity N (%)
Hypertension 88 (78.6)
Tobacco use 61 (54.5)
Hypercholesterolemia 57 (50.9)
Coronary disease 50 (44.6)
Diabetes mellitus 31 (27.7)
Arrhythmias 9 (8.0)
Renal disease* 5 (4.5)
*Defined as serum creatinine 2.0 mg/dL.included in the analysis on an intent-to-treat basis.
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stent was used in 46 procedures (41%), and multiple stents
were placed in 40 procedures (36%). Of these, 75 stents
were self-expanding, and the rest were balloon-expandable.
A 6F sheath was used to perform 104 procedures (93%),
seven procedures were performed through a 7F sheath, and
one through an 8F sheath.
A closure device was attempted after 99 procedures
(88%) and was successful in 92 attempts (93% success rate).
Overall, a closure device was successfully placed at the
conclusion of 82% of procedures; in the rest, hemostasis
was obtained by manual groin compression.
The average length of the procedure was 72  31
minutes (range, 17 to 175 minutes), with an average time
to mobilization of 1.4  1.3 hours and average time to
discharge of 2.8  1.2 hours. Same-day discharge was
achieved after 103 procedures. Nine patients (8%) were
admitted for overnight observation. Four patients were
admitted for lack of support mechanisms at home. One
patient was admitted for chest pain but was found not to
have had a myocardial infarction, and one patient was
admitted for observation of transient bradycardia, which
spontaneously resolved. One patient had a major puncture
site hematoma requiring blood transfusion, and two pa-
tients had minor hematomas. Of the three patients with
hematomas, two had what was assumed to be successful
deployment of a closure device, whereas in one patient,
deployment of a closure device was not attempted. After
procedures in which a closure device was successfully de-
ployed, patients were discharged to home on the same day
95% of the time, while 80% of patients undergoing manual
groin compression underwent same day discharge.
Eight of the admissions had TASC A or B lesions, and
one patient had a TASC C lesion. Eight of the nine admis-
sions had a length of stay of 1 day, and the patient with
chest pain stayed 4 days. In patients discharged the same
day, there were no deaths or unplanned readmissions 30
days of the procedure. The average postprocedural cost for
patients discharged the same day was $320 per patient,
which contrasts with $1800 for routine overnight observa-
tion.
There were three treatment failures, at 13 days, 17 days,
and 27 days. These patients were successfully treated with
open elective surgical intervention.
DISCUSSION
The last decade has witnessed striking technologic ad-
Table II. Location of intervention
Location N (%)
Common Iliac 20 (17.9)
External Iliac 18 (16.1)
Common femoral 4 (3.6)
Superficial femoral 53 (47.3)
Popliteal 41 (36.6)vances that have radically altered the manner in which carehas been delivered to patients with arterial occlusive dis-
ease. With the development of catheter-based techniques
to treat patients with intermittent claudication, it becomes
the responsibility of the operator to perform these proce-
dures in a safe, fiscally responsible, and cost-effective man-
ner. In the past, it has been considered the standard of care
to admit these patients to the hospital postprocedure for
overnight observation in hopes of recognizing complica-
tions in a timely fashion. In our experience, complications
have been infrequent and occurred in the early postproce-
dure period. This led us to attempt to modify our practice
guidelines by routinely discharging patients on the day of
their procedure. The results of this study confirm that
peripheral angioplasty in patients with intermittent claudi-
cation can be performed in a cost-effective manner without
compromising clinical outcomes.
Several studies9-14 have addressed the topic of outpa-
tient angioplasty. Although successful, most of their pa-
tients were prescreened or preselected for inclusion in the
study. In addition, most of these procedures were per-
formed on single arterial segments, and stents were rarely
used. In contrast, we assumed that all patients with claudi-
cation undergoing PTA had an equal probability of being
discharged, and thereby avoided selection bias by including
patients having extensive procedures on multiple arterial
segments in our study protocol. Still, we were able to
discharge 92% of our patients on the day of their interven-
tion. The safety of this approach is evidenced by the fact no
patients died or had unplanned readmissions to the hospital
30 days of their procedure.
Although all of the patients in our series had claudica-
tion, we and others15-18 have extended percutaneous inter-
ventions to those patients with limb threat, with gratifying
results. We have found that selected patients with limb
threat as their indication for intervention can be discharged
on the day of the procedure. The site of intervention,
length of the arterial segment treated, or the number of
stents placed did not affect the chance of admission. Many
complications of peripheral angioplasty are related to punc-
ture site complications.19,20 Interestingly, almost half of
our admissions were unrelated to medical problems and
were due to a lack of adequate social support at home.
Perhaps with better planning and foresight on our part,
some of these admissions could have been prevented.
Traditionally, patients undergoing peripheral angio-
plasty have been admitted to the hospital for overnight
observation. However, preservation of health care re-
sources has become increasingly important. In our area and
in many parts of the country, hospitals are running at their
maximum capacity, and bed space is at a premium. Limiting
unnecessary admissions and optimal utilization of available
resources would help to alleviate this problem. In addition,
same-day discharge after PTA can result in significant cost
savings. In our institution, our patients are observed in an
observation unit rather than a recovery room, allowing
for a substantial reduction in hospital cost. Our average
postprocedural cost for patients undergoing same day
discharge was $320 compared with the $1800 institu-
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monitored medical-surgical bed.
CONCLUSION
Same day discharge after peripheral angioplasty in pa-
tients with intermittent claudication is safe, cost-effective,
and does not adversely affect patient outcomes. Determi-
nation of the need for admission can usually be made 2
hours after the procedure. Attention to the social needs of
the patient and avoidance of puncture site complications
should minimize hospital admission. Although we prefer-
entially use closure devices, we were able to successfully
discharge to home on the same day 80% of patients under-
going manual compression. Those who do not use closure
devices should not be dissuaded from attempting same-day
discharge. We conclude that routine admission after pe-
ripheral percutaneous intervention in patients with claudi-
cation is unnecessary and should no longer be considered
the standard of care.
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